Brokers Set Expectations for Immunovant, Inc.'s FY2028 Earni

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities research analysts at HC Wainwright raised their FY2028 earnings per share estimates for shares of Immunovant in a research note issued to investors on Tuesday, February 13th. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of $2.16 for the year, […]

Related Keywords

United States , America , Peter Salzmann , Piper Sandler , Marks Levine , Nasdaq , Nuveen Asset Management , Wolfe Research , Weiss Multi Strategy Advisers , Blue Owl Capital Holdings , Immunovant Company Profile , Securities Exchange Commission , Immunovant Inc , Cantor Fitzgerald , Deutsche Bank Aktiengesellschaft , Free Report , Bank Aktiengesellschaft , Get Free Report , Owl Capital Holdings , Capital Investment Management , Multi Strategy Advisers , Asset Management , Octagon Capital Advisors , Capital Advisors , Exchange Commission , Immunovant Daily , Immunovant , Nasdaq Imvt , Imvt , Medical , Earnings Estimates , Hc Wainwright ,